KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

During the Trading Day
0.755 +0.055 / +7.86%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.75 -0.005 / -0.66%
 
Volume: 51.1K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues17.7M20.3M6.1M44.0K
 
 
 
 
 
Depreciation And Amortization843.0K595.0K304.0K298.0K
 
 
 
 
 
 
Operating ExpensesGross Income16.9M19.7M5.8M--
 
 
 
 
General Expenses23.0M20.8M29.3M40.7M
 
 
 
 
 
Research And Development18.9M17.6M24.5M32.6M
 
 
 
 
 
Total Operating Expenses23.8M21.4M29.6M41.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-1.2M-23.5M-40.9M
 
 
 
 
 
Extraordinary Credit2.0K0.000.000.00
 
 
Extraordinary Charge0.00-1.1M-39.0K0.00
 
 
 
Interest Expense On Debt----185.0K1.1M
 
 
 
Other Expenses913.0K40.0K152.0K-39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-2.2M-23.5M-41.9M
 
 
 
 
 
Net Income-5.1M-2.2M-23.5M-41.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.1M24.1M2.1M24.3M
 
 
 
 
 
Shares To Calculate EPS Diluted24.1M24.1M2.1M24.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.02-$1.15-$11.22-$1.73
 
 
 
 
 
EPS Diluted-$0.21-$0.09-$11.22-$1.73
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account